143519-58-8|[3aS-(3aalpha,4beta,6aalpha)]-N-[5-(Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-8-L-leucine-22-D-tryptophan-25-L-tyrosine-somatostatin-28 (sheep)

Current Location
Home Products
detail

[3aS-(3aalpha,4beta,6aalpha)]-N-[5-(Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-8-L-leucine-22-D-tryptophan-25-L-tyrosine-somatostatin-28 (sheep) | CAS:143519-58-8

[3aS-(3aalpha,4beta,6aalpha)]-N-[5-(Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-8-L-leucine-22-D-tryptophan-25-L-tyrosine-somatostatin-28 (sheep)

Name：[3aS-(3aalpha,4beta,6aalpha)]-N-[5-(Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-8-L-leucine-22-D-tryptophan-25-L-tyrosine-somatostatin-28 (sheep)
CAS：143519-58-8
Synonyms：
Molecular Formula：C₁₄₈H₂₂₃N₄₃O₄₂S₃
Molecular Weight：3372.81
EINESC：

Description

Properties

Density	1.56±0.1 g/cm3 (20 ºC

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Rational design of indoleamine 2,3-dioxygenase inhibitors.Ute F Röhrig et al.Journal of medicinal chemistry, 53(3), 1172-1189 (2010-01-09) Affinity chromatography on immobilized "biomimetic" ligands. Synthesis, immobilization and chromatographic assessment of an immunoglobulin G-binding ligand.S F Teng et al.Journal of chromatography. B, Biomedical sciences and applications, 740(1), 1-15 (2000-05-08)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News